Skip to main content

Annexon, Inc.

ANNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001528115

In the last 90 days, Annexon, Inc. insiders filed 1 open-market purchase and 0 sales; 216 institutions reported holding it in 13F filings for Q2 2026, worth $1.02B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Annexon, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
1 filing
1 insider, $99.8K in total
Open-market sells
0 filings
Insiders trading
1
Net value
+$99.8K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Annexon, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Annexon, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Love DouglasPRESIDENT AND CEO390,476Sep 25, 20262
Blumenkranz Mark S.Director–Aug 12, 20261
Satter Muneer ADirector10,342,134IndirectJun 15, 20264
Jones William A JrDirector–Jun 15, 20261
Waddill William D.Director–Jun 15, 20261
Choi JungDirector33,000IndirectJun 15, 20262
Yednock TedEVP & CHIEF INNOVATION OFFICER184,807Jun 15, 20264
Carson William H.Director78,405Jun 15, 20268
Cockroft Bettina M.Director–Jun 15, 20261
Lew JenniferEVP & CHIEF FINANCIAL OFFICER170,700Mar 4, 20263
Dananberg JamieCHIEF MEDICAL OFFICER123,582Mar 4, 20263
Overdorf MichaelEVP & CHIEF BUSINESS OFFICER182,625Mar 4, 20263
Artis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER180,093Mar 4, 20263
Wiggans Thomas GDirector–Jun 9, 20250
Bain Capital Life Sciences Fund, L.P.10% Owner5,701,926IndirectMay 30, 20230
BCIP Life Sciences Associates, LP10% Owner5,701,926IndirectMay 30, 20230
Bain Capital Life Sciences Partners, LP10% Owner5,701,926IndirectMay 30, 20230
Bain Capital Life Sciences Investors, LLC10% Owner5,701,926IndirectMay 30, 20230
Mattheakis LarryEVP & Chief Scientific Officer17,188Jul 13, 20220
Keswani Sanjay ChandruEVP & Chief Medical Officer12,500Feb 15, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 25, 2026 (view filing)4:15 PM ETSep 241 dayLove DouglasPRESIDENT AND CEOPPurchase+26.1K$3.83+$99.8K+7.2%390.5K after
May 29, 2026 (view filing)May 281 daySatter Muneer ADirectorPPurchase+613.5K$5.41+$3.32M+6.3%10.3M after
May 13, 2026 (view filing)May 112 daysCarson William H.DirectorPPurchase+8.00K$5.78+$46.2K+11.4%78.4K after10b5-1
Apr 14, 2026 (view filing)Apr 104 daysCarson William H.DirectorPPurchase+8.00K$6.20+$49.6K+12.8%70.4K after10b5-1
Mar 12, 2026 (view filing)Mar 102 daysCarson William H.DirectorPPurchase+8.00K$5.67+$45.4K+14.7%62.4K after10b5-1
Mar 4, 2026 (view filing)Mar 22 daysArtis Dean RichardEVP & CHIEF SCIENTIFIC OFFICERSSale−5.89K$5.43−$32.0K−3.2%180.1K after
Mar 4, 2026 (view filing)Mar 22 daysYednock TedEVP & CHIEF INNOVATION OFFICERSSale−5.57K$5.42−$30.2K−3.5%154.2K after
Mar 4, 2026 (view filing)Mar 22 daysOverdorf MichaelEVP & CHIEF BUSINESS OFFICERSSale−4.34K$5.42−$23.5K−2.3%182.6K after
Mar 4, 2026 (view filing)Mar 22 daysDananberg JamieCHIEF MEDICAL OFFICERSSale−5.82K$5.43−$31.6K−4.5%123.6K after
Mar 4, 2026 (view filing)Mar 22 daysLew JenniferEVP & CHIEF FINANCIAL OFFICERSSale−5.57K$5.42−$30.2K−3.2%170.7K after
Feb 20, 2026 (view filing)Feb 182 daysArtis Dean RichardEVP & CHIEF SCIENTIFIC OFFICERSSale−5.29K$5.10−$27.0K−4.1%123.5K after
Feb 20, 2026 (view filing)Feb 182 daysYednock TedEVP & CHIEF INNOVATION OFFICERSSale−7.86K$5.11−$40.1K−7.5%97.2K after
Feb 20, 2026 (view filing)Feb 182 daysOverdorf MichaelEVP & CHIEF BUSINESS OFFICERSSale−6.22K$5.10−$31.7K−4.8%124.5K after
Feb 20, 2026 (view filing)Feb 182 daysDananberg JamieCHIEF MEDICAL OFFICERSSale−5.29K$5.10−$27.0K−6.7%73.2K after
Feb 20, 2026 (view filing)Feb 182 daysLew JenniferEVP & CHIEF FINANCIAL OFFICERSSale−7.85K$5.11−$40.1K−6.5%113.8K after
Jan 2, 2026 (view filing)Dec 30, 20253 daysCarson William H.DirectorPPurchase+4.12K$5.02+$20.7K+8.2%54.4K after10b5-1
Dec 3, 2025 (view filing)Dec 12 daysCarson William H.DirectorPPurchase+4.12K$4.47+$18.4K+8.9%50.3K after10b5-1
Dec 3, 2025 (view filing)Dec 12 daysChoi JungDirectorPPurchase+33.0K$4.19+$138.3KNew position33.0K after
Nov 21, 2025 (view filing)Nov 20-211 daySatter Muneer ADirectorPPurchase+822.6K$4.38+$3.60M+9.2%9.73M after2 lots
Nov 19, 2025 (view filing)Nov 17-192 daysSatter Muneer ADirectorPPurchase+1.50M$3.37+$5.05M+20.3%8.91M after3 lots
Oct 31, 2025 (view filing)Oct 301 dayCarson William H.DirectorPPurchase+4.12K$3.17+$13.0K+9.8%46.2K after10b5-1
Oct 2, 2025 (view filing)Sep 302 daysCarson William H.DirectorPPurchase+4.12K$3.05+$12.6K+10.8%42.1K after10b5-1
Sep 4, 2025 (view filing)Sep 22 daysCarson William H.DirectorPPurchase+4.12K$2.09+$8.60K+12.2%37.9K after10b5-1
Aug 1, 2025 (view filing)Jul 302 daysCarson William H.DirectorPPurchase+4.12K$2.43+$10.0K+13.8%33.8K after10b5-1
Jul 16, 2025 (view filing)Jul 142 daysYednock TedEVP & CHIEF INNOVATION OFFICERSSale−1.12K$2.58−$2.88K−1.1%105.1K after
Jul 16, 2025 (view filing)Jul 142 daysLew JenniferEVP & CHIEF FINANCIAL OFFICERSSale−1.12K$2.58−$2.88K−0.9%121.6K after
Jul 16, 2025 (view filing)Jul 142 daysOverdorf MichaelEVP & CHIEF BUSINESS OFFICERSSale−853$2.61−$2.23K−0.6%130.7K after
Jul 1, 2025 (view filing)Jun 301 dayCarson William H.DirectorPPurchase+4.12K$2.46+$10.1K+16.1%29.7K after10b5-1
Feb 20, 2025 (view filing)Feb 182 daysDananberg JamieCHIEF MEDICAL OFFICERSSale−5.52K$2.96−$16.3K−14.2%33.5K after
Feb 20, 2025 (view filing)Feb 182 daysArtis Dean RichardEVP & CHIEF SCIENTIFIC OFFICERSSale−5.51K$2.97−$16.4K−6.2%83.8K after
Feb 20, 2025 (view filing)Feb 182 daysYednock TedEVP & CHIEF INNOVATION OFFICERSSale−8.35K$2.91−$24.3K−12.0%61.2K after
Feb 20, 2025 (view filing)Feb 182 daysOverdorf MichaelEVP & CHIEF BUSINESS OFFICERSSale−6.62K$2.95−$19.5K−7.1%86.6K after
Feb 20, 2025 (view filing)Feb 182 daysLew JenniferEVP & CHIEF FINANCIAL OFFICERSSale−6.91K$2.92−$20.2K−8.2%77.8K after
Feb 18, 2025 (view filing)Feb 135 daysLove DouglasPRESIDENT AND CEOSSale−5.02K$2.95−$14.8K−1.4%351.6K after
Feb 18, 2025 (view filing)Feb 135 daysLew JenniferEVP & CHIEF FINANCIAL OFFICERSSale−1.79K$2.98−$5.32K−2.1%84.7K after
Feb 18, 2025 (view filing)Feb 135 daysYednock TedEVP & CHIEF INNOVATION OFFICERSSale−1.78K$2.99−$5.33K−2.5%69.6K after
Feb 18, 2025 (view filing)Feb 135 daysOverdorf MichaelEVP & CHIEF BUSINESS OFFICERSSale−1.43K$2.99−$4.26K−1.5%93.2K after
Dec 4, 2024 (view filing)Dec 22 daysCarson William H.DirectorPPurchase+3.20K$5.33+$17.1K+14.3%25.6K after10b5-1
Oct 17, 2024 (view filing)Oct 152 daysYednock TedEVP & CHIEF INNOVATION OFFICERSSale−5.41K$7.41−$40.1K−7.0%71.4K after10b5-1
Oct 2, 2024 (view filing)Oct 11 dayCarson William H.DirectorPPurchase+3.20K$5.97+$19.1K+16.7%22.4K after10b5-1
Sep 20, 2024 (view filing)Sep 191 dayYednock TedEVP & CHIEF INNOVATION OFFICERSSale−4.50K$7.10−$31.9K−100.0%0 after10b5-1
Sep 16, 2024 (view filing)Sep 124 daysYednock TedEVP & CHIEF INNOVATION OFFICERSSale−5.50K$6.16−$33.9K−55.0%4.50K after10b5-1
Sep 6, 2024 (view filing)Sep 51 dayYednock TedEVP & CHIEF INNOVATION OFFICERSSale−5.50K$5.64−$31.0K−35.5%10.0K after10b5-1
Sep 4, 2024 (view filing)Sep 31 dayCarson William H.DirectorPPurchase+3.20K$5.48+$17.5K+20.0%19.2K after10b5-1
Aug 30, 2024 (view filing)Aug 291 dayYednock TedEVP & CHIEF INNOVATION OFFICERSSale−5.50K$5.95−$32.7K−26.2%15.5K after10b5-1
Aug 5, 2024 (view filing)Aug 14 daysCarson William H.DirectorPPurchase+3.20K$6.24+$20.0K+25.0%16.0K after10b5-1
Jul 17, 2024 (view filing)Jul 152 daysOverdorf MichaelEVP & CHIEF BUSINESS OFFICERSSale−784$6.02−$4.72K−0.8%94.6K after
Jul 17, 2024 (view filing)Jul 152 daysLew JenniferEVP & CHIEF FINANCIAL OFFICERSSale−1.10K$6.03−$6.66K−1.3%86.5K after
Jul 17, 2024 (view filing)Jul 152 daysYednock TedEVP & CHIEF INNOVATION OFFICERSSale−1.11K$6.02−$6.66K−1.5%71.4K after
Jul 2, 2024 (view filing)Jul 11 dayCarson William H.DirectorPPurchase+3.20K$5.00+$16.0K+33.3%12.8K after10b5-1